Third Sickle Cell Product From Pfizer’s Global Blood Buyout Hits Snag

The drugmaker reported a negative Phase III study for inclacumab, after a partial clinical hold for osivelotor and pulling Oxbryta from the market.Read More

What's Trending

Toronto police surrounding U.S. Consulate after officers found evidence of gunfire outside building

Gordie Howe International Bridge opens, ending years of delays

Toronto police surrounding U.S. Consulate after officers found evidence of gunfire outside building

Orange County Schools Limit Student Phone Access Under State Law

How the mobile home law change will impact San Diego

How the new federal housing law changes real estate investing for institutions

Ellison Addresses Paramount-Warner Bros. Merger Delay in Staff Memo

Why Hire the Social Media Victims Law Center for a Social Media Addiction Lawsuit?

Third Sickle Cell Product From Pfizer’s Global Blood Buyout Hits Snag

Toronto police surrounding U.S. Consulate after officers found evidence of gunfire outside building

Gordie Howe International Bridge opens, ending years of delays

Toronto police surrounding U.S. Consulate after officers found evidence of gunfire outside building

South Africa’s Ramaphosa calls for African action on migration

Leave A Reply Cancel Reply

What's Trending

Third Sickle Cell Product From Pfizer’s Global Blood Buyout Hits Snag

Related Posts

Leave A Reply Cancel Reply

Subscribe to MGSN